Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit of NOVOEIGHT is substantial. |
Clinical Added Value
| no clinical added value |
NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments. |
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
jawwDhv3gG88CEUU
Listen
Français